Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype

Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering

(2013) Mark J. Pletcher   ANNALS OF INTERNAL MEDICINE

Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow

(2009) Kathleen A. Boyd et al.   ADDICTION

Divergent Effects of α-Tocopherol and Vitamin C on the Generation of Dysfunctional HDL Associated with Diabetes and the Hp 2-2 Genotype

(2009) Rabea Asleh et al.   ANTIOXIDANTS & REDOX SIGNALING

Haptoglobin Genotype: A Determinant of Cardiovascular Complication Risk in Type 1 Diabetes

(2008) T. Costacou et al.   DIABETES

Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype

(2008) R. Asleh et al.   DIABETES

Vitamins E and C in the Prevention of Cardiovascular Disease in Men

(2008) Howard D. Sesso   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype

(2007) Uzi Milman et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The antioxidant and pro-oxidant activity of vitamin C and troloxin vitro: a comparative study

(2007) Borut Poljšak et al.   JOURNAL OF APPLIED TOXICOLOGY